A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)

drug protocol number
MV22009
drug sponsor
Roche
drug study
Pegasys
drug trial site
King Fahad University Hospital (Al-Khobar), Armed Forces Hospital (Kharj)
drug status
Completed
drug phase